Pegloticase and Chronic Gout

被引:4
|
作者
Ea, Hang-Korng [1 ]
Chales, Gerard [2 ]
Liote, Frederic [1 ]
机构
[1] Univ Paris Diderot, Paris, France
[2] Univ Rennes, Rennes, France
来源
关键词
D O I
10.1001/jama.2011.1616
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1979 / 1979
页数:1
相关论文
共 50 条
  • [31] Evaluation of the efficacy and safety of pegloticase for the treatment of chronic refractory gout through meta-analysis
    Fan, Tianci
    Wang, Yifan
    Song, Tongqing
    Sun, Yan
    INTRACTABLE & RARE DISEASES RESEARCH, 2023, 12 (02) : 114 - 117
  • [32] Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout
    Lipsky, Peter E.
    Calabrese, Leonard H.
    Kavanaugh, Arthur
    Sundy, John S.
    Wright, David
    Wolfson, Marsha
    Becker, Michael A.
    ARTHRITIS RESEARCH & THERAPY, 2014, 16 (02)
  • [33] Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout
    Peter E Lipsky
    Leonard H Calabrese
    Arthur Kavanaugh
    John S Sundy
    David Wright
    Marsha Wolfson
    Michael A Becker
    Arthritis Research & Therapy, 16
  • [34] Pegloticase: A Novel Agent for Treatment-Refractory Gout
    Shannon, Jennifer A.
    Cole, Sabrina W.
    ANNALS OF PHARMACOTHERAPY, 2012, 46 (03) : 368 - 376
  • [35] LEFLUNOMIDE CO-THERAPY WITH PEGLOTICASE IN UNCONTROLLED GOUT
    Masri, K.
    Winterling, K.
    Lamoreaux, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 450 - 450
  • [36] The Needle or Knife Pegloticase for Refractory Crippling Gout in a Nonagenarian
    Choi, Noah
    Eickhoff, Jeffrey
    Keith, Michael
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2017, 23 (06) : 343 - 343
  • [37] Serum Uric Acid As a Biomarker for Mitigation of Infusion Reactions in Patients Treated with Pegloticase for Refractory Chronic Gout
    Baraf, Herbert S. B.
    Yood, Robert A.
    Sundy, John S.
    Ottery, Faith D.
    Becker, Michael A.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S813 - S814
  • [38] THE FREQUENCY OF FLARES IN SUBJECTS WITH CHRONIC REFRACTORY GOUT TREATED WITH PEGLOTICASE IS RELATED TO VARIATION IN THE LEVEL OF PLASMA URATE
    Calabrese, L.
    Fields, T.
    Yeo, A.
    Lipsky, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 141 - 141
  • [39] Dissociation Between Clinical Benefit and Persistent Urate Lowering in Patients with Chronic Refractory Gout Treated with Pegloticase
    Pillinger, Michael H.
    Fields, Theodore R.
    Yeo, Anthony E.
    Lipsky, Peter E.
    JOURNAL OF RHEUMATOLOGY, 2020, 47 (04) : 605 - 612
  • [40] Infusion-Related Reactions With Pegloticase, a Recombinant Uricase for the Treatment of Chronic Gout Refractory to Conventional Therapy
    Baraf, Herbert S. B.
    Yood, Robert A.
    Ottery, Faith D.
    Sundy, John S.
    Becker, Michael A.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2014, 20 (08) : 427 - 432